Renal Cancer - Results from #3580

Folic Acid Reduces Mucositis in Metastatic Renal Cell Carcinoma Patients: A Retrospective Study. May 28, 2019

Radioablation of Hepatic Metastases from Renal Cell Carcinoma With Image-guided Interstitial Brachytherapy. May 28, 2019

Survival and clinical prognostic factors in metastatic non-clear cell renal cell carcinoma treated with targeted therapy: A multi-institutional, retrospective study using the Korean metastatic renal cell carcinoma registry. May 27, 2019

Diagnostic and prognostic value of the detection of hTERT mRNA in renal tumors. May 27, 2019

NCCN Guidelines Updates: Management of Metastatic Kidney Cancer. May 27, 2019

Efficacy and safety of perioperative appliance of sunitinib in patients with metastatic or advanced renal cell carcinoma: A systematic review and meta-analysis. May 24, 2019

Expression and clinical value of CD105 in renal cell carcinoma based on data mining in The Cancer Genome Atlas. May 24, 2019

Is Axitinib Still a Valid Option for mRCC in the Second-Line Setting? Prognostic Factor Analyses From the AXIS Trial. May 24, 2019

Molecular Mechanisms in Clear Cell Renal Cell Carcinoma: Role of miRNAs and Hypermethylated miRNA Genes in Crucial Oncogenic Pathways and Processes. May 23, 2019

Protection from injury of organs adjacent to a renal tumor during percutaneous cryoablation. May 23, 2019

Patient characteristics and treatments one year after diagnosis of renal cancer in 2015 according to the presence or absence of metastasis and a history of another tumour: A national observational study. May 23, 2019

Methylation Signature for Prediction of Progression Free Survival in Surgically Treated Clear Cell Renal Cell Carcinoma. May 22, 2019

c-FLIP and CD95 signaling are essential for survival of renal cell carcinoma. May 22, 2019

Extent of lymph node dissection improves overall survival in pT3N0 non-metastatic renal cell carcinoma patients treated with radical nephrectomy: a propensity score-based analysis. May 22, 2019

Management of High Complexity Renal Masses in Partial Nephrectomy: A Multicenter Analysis May 21, 2019

Reassessing the Role of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in 2019. May 21, 2019

A phase II trial of intermittent nivolumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior anti-angiogenic therapy. May 21, 2019

Role of Active Surveillance for Localized Small Renal Masses. May 20, 2019

Safety and Efficacy of Nivolumab in Patients With Metastatic Renal Cell Carcinoma and End-stage Renal Disease at 2 Centers. May 20, 2019

Cytoreductive nephrectomy in metastatic kidney cancer: what do we do now? May 20, 2019

Page 180 of 457